| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/JTO.0B013E318227142D |
| P698 | PubMed publication ID | 21841504 |
| P50 | author | Carlie Sigel | Q47115818 |
| P2093 | author name string | William D Travis | |
| Gregory J Riely | |||
| Maureen F Zakowski | |||
| Natasha Rekhtman | |||
| Andre L Moreira | |||
| Raymond H Thornton | |||
| P433 | issue | 11 | |
| P921 | main subject | lung carcinoma | Q18556110 |
| cell biology | Q7141 | ||
| P304 | page(s) | 1849-1856 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Journal of Thoracic Oncology | Q2448056 |
| P1476 | title | Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens | |
| P478 | volume | 6 |
| Q48249881 | Accuracy of cytology in sub typing non small cell lung carcinomas. |
| Q35110001 | Advances in fine needle aspiration cytology for the diagnosis of pulmonary carcinoma |
| Q50947169 | Analytic inquiry: Molecular testing in lung cancer. |
| Q41528825 | Automated Classification of Lung Cancer Types from Cytological Images Using Deep Convolutional Neural Networks |
| Q31146982 | Big data from small samples: Informatics of next-generation sequencing in cytopathology. |
| Q42735804 | Clinical significance of the 'not otherwise specified' subtype in candidates for resectable non-small cell lung cancer |
| Q38983738 | Committee I: Indications for pulmonary cytology sampling methods |
| Q38606005 | Cytology nomenclature and 2015 World Health Organization classification of lung cancer |
| Q54332533 | Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma. |
| Q49136811 | Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification |
| Q89587219 | Decision Support System for Lung Cancer Using PET/CT and Microscopic Images |
| Q35875227 | Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification |
| Q47799374 | Diagnostic concordance of non-small cell lung carcinoma subtypes between biopsy and cytology specimens obtained during the same procedure |
| Q34777840 | EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients |
| Q101059831 | Expanding the utility of cytology preparations in cancer biomarker testing |
| Q93382354 | Fine-needle aspiration cytology of non-small cell lung carcinoma: A paradigm shift |
| Q38263944 | Granulomatous inflammation and organizing pneumonia: Role of computed tomography-guided lung fine needle aspirations, touch preparations and core biopsies in the evaluation of common non-neoplastic diagnoses |
| Q33904760 | Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma |
| Q59796396 | Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker |
| Q64107762 | Immune-enrichment of non-small cell lung cancer baseline biopsies for multiplex profiling define prognostic immune checkpoint combinations for patient stratification |
| Q33611088 | Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario |
| Q50135786 | MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies |
| Q57425418 | Molecular Typing of Lung Adenocarcinoma on Cytological Samples in the Next-Generation Sequencing Era |
| Q62081857 | Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis |
| Q39463253 | Morphologic Accuracy in Differentiating Primary Lung Adenocarcinoma From Squamous Cell Carcinoma in Cytology Specimens |
| Q51643436 | Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens. |
| Q41632957 | Pneumothorax with prolonged chest tube requirement after CT-guided percutaneous lung biopsy: incidence and risk factors |
| Q28083663 | Promising targets and current clinical trials in metastatic squamous cell lung cancer |
| Q43195719 | Pulmonary adenocarcinoma histology |
| Q38048579 | Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy |
| Q44574005 | Subtyping of pulmonary adenocarcinoma in cytologic specimens: the next challenge |
| Q36043762 | Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients |
| Q35951079 | The evolving role of the pathologist in the management of lung cancer |
| Q27010437 | The pivotal role of pathology in the management of lung cancer |
| Q54024842 | The squamous situation: Ancillary testing in pulmonary squamous cell carcinoma and implications for cytology laboratories. |
| Q42111371 | Utility of immunochemistry in cytology |
| Q54503444 | [Non-small cell lung cancer. Subtyping and predictive molecular marker investigations in cytology]. |
Search more.